LevoCept

DRUG2 trials

Sponsors

Sebela Women's Health Inc.

Conditions

ContraceptionWomen at Risk for Pregnancy

Phase 2

Evaluation of the Efficacy and Safety of LevoCept

CompletedNCT02882191

Sebela Women's Health Inc.Contraception

Start: 2016-11-01End: 2020-11-12Updated: 2026-04-23

Phase 3

Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

Not yet recruitingNCT04457076

Sebela Women's Health Inc.Contraception, Women at Risk for Pregnancy

Start: 2026-06-01End: 2032-06-01Target: 1525Updated: 2025-05-22